Reuters logo
BRIEF-Oxford Biomedica notes acceptance by FDA of a biologics license application filing for CTL019
March 30, 2017 / 6:21 AM / in 7 months

BRIEF-Oxford Biomedica notes acceptance by FDA of a biologics license application filing for CTL019

March 30 (Reuters) - Oxford Biomedica Plc

* Oxford Biomedica notes acceptance by FDA of a biologics license application (BLA) filing for CTL019

* Oxford Biomedica will also receive undisclosed royalties on potential future sales of Novartis Car-T products. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below